Skip to content

Clinical trials

Terminated Alzheimer Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Terminated Country / region: Netherlands Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20092
20111
20121
20131
20142
20155
20162
20172
20181
20203
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Biogen2
FORUM Pharmaceuticals Inc2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Alector Inc.1
AstraZeneca1
Central Clinical Hospital of the Russian Academy of Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease30
Dementia10
Brain Diseases4
Neurodegenerative Diseases3
Central Nervous System Diseases2
Cognitive Dysfunction2
Mental Disorders2
Nervous System Diseases2
Angina, Stable1
Cerebrovascular Disorders1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.